Compare Charles Schwab Corporation Common Stock (SCHW) vs Tilray Brands Inc (TLRY) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Charles Schwab Corporation Common Stock vs Tilray Brands Inc — how do they compare? Charles Schwab Corporation Common Stock trades at $97 (market cap $167.52B), while Tilray Brands Inc trades at $3.6 (market cap $530.54M). The key difference: Charles Schwab Corporation Common Stock is far larger — about 315.8× Tilray Brands Inc's market cap, and Charles Schwab Corporation Common Stock pays a 1.32% dividend while Tilray Brands Inc pays none. Which is the better fit depends on your goals — on Pluang, investors hold Charles Schwab Corporation Common Stock for 85 Days and Tilray Brands Inc for 31 Days on average.
| SCHW | TLRY | |
|---|---|---|
Market Cap | $167.52B | $530.54M |
Volume | 6,554,126 | 9,099,075 |
Sector | Financials | Health |
52-Week High | $113.65 | $21.00 |
52-Week Low | $85.35 | $3.57 |
Typical Hold Time | 85 Days | 31 Days |
Enterprise Value | $153.97B | $684.46M |
Dividend Yield | 1.32% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Charles Schwab (SCHW) trades at $95.58, down 1.26% today, with a bearish technical signal. The stock shows strong fundamentals, with Q2 2026 EPS beating expectations at $1.62 and revenue growth to $23.92B in 2025. Analyst consensus is bullish, with a $119.92 price target, supported by recent news of a secondary listing on the Texas Stock Exchange and AI integration for advisors.
Outlook remains positive due to earnings momentum and market share gains, but risks include competitive pressures and interest rate sensitivity. The stock offers upside from current levels if execution continues, though technical weakness may persist near-term.
TLRY trades at $3.715, down 1.72% on the day and near its 52-week low, reflecting persistent bearish technical momentum. The company reported revenue of $821.31M in 2025 but a substantial net loss of -$2.19B, with negative cash flow from operations. Recent quarters show consistent earnings misses versus expectations, though analyst consensus suggests a high price target of $65.01 amid mixed sentiment.
The outlook remains challenged by profitability issues and high debt, but potential catalysts include U.S. cannabis regulatory changes. Investment opportunities hinge on speculative regulatory shifts, while risks include ongoing losses, competitive pressures, and reliance on financing activities to sustain operations.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Charles Schwab Corporation Common Stock
Charles Schwab operates in brokerage, banking, and asset-management businesses. The company runs a large network of brick-and-mortar brokerage branch offices, a well-established online investing website, and has mobile trading capabilities. It also operates a bank and a proprietary asset management business and offers services to independent investment advisors. The company is among the largest firms in the investment business, with over $8 trillion of client assets at the end of 2021. Nearly all of its revenue is from the United States.
Read more on SCHW →About Tilray Brands Inc
Tilray is a Canadian company that grows and sells medical and recreational cannabis. In 2021, Aphria acquired Tilray in a reverse merger and adopted the Tilray name. Most of its sales come from Canada and international medical cannabis exports, while its U.S. business focuses on CBD products and alcohol.
Read more on TLRY →
